Sign In
Buy INRLF
$2.74
+0.160 (+6.20%)
At Close: Jun 03, 2026
Former vaccine tsar accuses Government of bad faith in cancelling Valneva deal
08:29pm, Tuesday, 23'rd Nov 2021 Evening Standard
Dame Kate Bingham criticised the decision to pull out of a deal with French pharmaceutical company Valneva which has a factory in Scotland.
Valneva signs purchase agreement with EC for supply of inactivated COVID-19 shot
06:23pm, Tuesday, 23'rd Nov 2021 Seeking Alpha
Why Are Valneva Shares Trading Higher Today?
06:15pm, Tuesday, 23'rd Nov 2021 Benzinga
Valneva SE (NASDAQ: VALN ) has signed an Advance Purchase Agreement (APA) with the European Commission (EC) to supply up to 60 million doses of its inactivated COVID-19 vaccine candidate VLA2001, over two years. The agreement follows the announcement made earlier this month that the EC had approved the APA. Under the terms Full story available on Benzinga.com
Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA2001
05:40pm, Tuesday, 23'rd Nov 2021 Intrado Digital Media
Saint- Herb lain (France ) , November 23 , 2021 Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it has signed an Advance Purchase Agreement (APA) with the European Commission (EC) to supply up to 60 million doses of its inactivated COVID-19 vaccine candidate, VLA2001, over two years. The agreement follows the announcement made earlier this month that the EC had approved the APA 1 .
Valneva (NASDAQ:VALN) Sees Unusually-High Trading Volume
04:42pm, Tuesday, 23'rd Nov 2021 Dakota Financial News
Shares of Valneva SE (NASDAQ:VALN) saw unusually-high trading volume on Tuesday . Approximately 3,550 shares changed hands during mid-day trading, a decline of 95% from the previous sessions volume of 65,166 shares.The stock last traded at $45.07 and had previously closed at $48.91. VALN has been the topic of a number of research reports. Jefferies []
PIR-Group by dad.at: Valneva mit 77 Prozent Monatsplus
06:49am, Wednesday, 17'th Nov 2021 Borse Social NetworkValneva to Present its Chikungunya Vaccine Candidate at the ASTMH 2021 Annual Meeting
04:45pm, Monday, 15'th Nov 2021 Intrado Digital Media
Saint - Herblain ( France), November 15 , 2021 Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced it will present its Chikungunya vaccine candidate, VLA1553, on November 18 and 19, 2021 during the American Society of Tropical Medicine & Hygiene (ASTMH) 2021 Annual Meeting.
Valneva SE Seeks $100 Million In U.S. IPO
04:09pm, Thursday, 29'th Apr 2021
Valneva SE has filed to raise $100 million U.S. public market investment.
Coronavirus: Netherlands won't use millions AstraZeneca vaccine doses, Valneva seeks 4,000 UK volunteers for jab trials
07:19am, Monday, 26'th Apr 2021
Most of 11mln doses of the AstraZeneca PLC (LON:AZN) COVID-19 vaccine due to be shipped to the Netherlands will go unused, it has been revealed. Jaap van Deldon, head of the vaccination department of
French vaccine maker Valneva launches Phase 3 trial of its COVID-19 shot after snubbing EU
07:45am, Thursday, 22'nd Apr 2021
Study will compare how immune systems respond to Valneva's vaccine candidate with the one jointly developed by AstraZeneca and the University of Oxford.
